Albumin Dosing Recommendations
For large-volume paracentesis (>5L) in cirrhotic patients, use 6-8 g of 20% or 25% albumin per liter of ascites removed; for all other indications in critically ill adults and pediatric patients, albumin should generally be avoided as it does not improve mortality or morbidity outcomes.
Context-Specific Dosing
Large-Volume Paracentesis (The Primary Indication)
- Standard dose: 6-8 g albumin per liter of ascites removed when >5L is drained 1
- Practical approach: Use 25 g for 5-6L removed, 50 g for 7-10L, and 75 g for >10L 2
- Recent evidence suggests lower doses (≤6 g/L) may be equally effective, though this requires further validation 3
- Formulation: Preferentially use 20-25% albumin solutions to minimize sodium load (5 times less sodium per gram compared to 5% solutions) 4
Volume Resuscitation (When Albumin Is Used)
- Maximum dose: Should not exceed 2 g per kg body weight in absence of active hemorrhage 4
- Practical calculation: For oncotic deficit correction, estimate dose as: (desired TSP - actual TSP) × plasma volume (40 mL/kg) × 2 4
- Formulation choice: Both 5% and 20% solutions expand plasma volume by approximately 11 mL per gram of albumin retained 5
- 20% albumin advantage: Expands plasma volume by 2-4 times the infused volume through interstitial fluid recruitment 6
Hemolytic Disease of Newborn
- Dose: 1 g/kg body weight given approximately 1 hour prior to exchange transfusion 4
- Caution: Avoid in hypervolemic infants
Critical Situations Where Albumin Should NOT Be Used
The 2024 ICTMG guidelines provide strong conditional recommendations against albumin in multiple scenarios 1:
- Critically ill adults with thermal injuries or ARDS for volume replacement
- Preterm neonates (<36 weeks) with respiratory distress
- Preterm neonates (<32 weeks or <1,500 g) for volume replacement
- Pediatric cardiovascular surgery for circuit priming or volume replacement 1
- Kidney replacement therapy for intradialytic hypotension
- Fluid removal when combined with diuretics in critically ill adults
- Pediatric gastrointestinal surgery: Overuse (>2 days postoperatively) increases hospital stay and complications 7
Important Nuance on Sepsis
While the Surviving Sepsis Campaign suggests albumin as a rescue fluid after large crystalloid volumes, the ICTMG guidelines found no mortality benefit in critically ill patients including those with sepsis 1. Crystalloids remain first-line, with albumin reserved only if massive crystalloid volumes threaten adverse effects.
Formulation Selection: 5% vs 20%
Prefer 20-25% albumin solutions for the following reasons:
- Lower sodium load: Same sodium content but 5 times less per gram of albumin 8
- Volume efficiency: Acts as true plasma expander, increasing volume by 2-4× infused amount 6
- Interstitial dehydration: Helps maintain intravascular volume at lower arterial pressures 6
5% albumin considerations:
- Contains electrolyte solution, easier to infuse due to lower viscosity 5
- Iso-oncotic, does not recruit additional fluid
- Avoid hypotonic 4% solutions in traumatic brain injury due to increased mortality risk 9
Administration Principles
- Route: Intravenous only 4
- Compatibility: Compatible with whole blood, packed RBCs, standard electrolytes and carbohydrates 4
- Incompatibility: Do NOT mix with protein hydrolysates, amino acids, or alcohol-containing solutions 4
- Monitoring: Check post-infusion total serum protein levels to assess effect 4
- Rate: Adjust based on hemodynamic response with safeguards against circulatory overload 4
Key Clinical Pitfalls
- Avoid target-based albumin strategies in sepsis—they do not improve mortality 9
- Do not use for chronic hypoalbuminemia (cirrhosis, nephrosis, malnutrition) unless acute stress supervenes 4
- Pediatric caution: In African children with severe febrile illness, albumin boluses increased mortality compared to no bolus 1
- Cost consideration: Albumin is significantly more expensive than crystalloids without proven mortality benefit in most scenarios 1